Status
Terminated
Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutramine and phenolphthalein. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.
Status
Terminated
Classification
Class I
Report Date
December 25, 2013
Termination Date
May 30, 2018